GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hanall Biopharma Co 009420.KS · KRW

Health Care · KRX · 🇰🇷 South Korea

Compare

37,100

+3.92%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Hanall Biopharma Co

Our reporting

Next results

20 Jan 2027

Due on 20 Jan 2027. on revenue of ₩24.00bn.

Past results

Reported against what analysts expected

28 Oct 202629 Jul 202629 Apr 202621 Jan 202629 Oct 202530 Jul 2025
Earnings per share58.61-368.095.42-125.416.0011.54
Forecast54.4051.66————
Revenue₩39.91bn₩44.28bn₩40.03bn₩37.55bn₩40.80bn₩40.68bn
Forecast₩24.00bn₩39.20bn₩38.70bn₩40.40bn₩41.20bn₩41.75bn

Key events

  1. 10 May 200610-for-1 share split
  2. 3 Jan 19961.02-for-1 share split
  3. 3 Jan 19951.02-for-1 share split
  4. 24 May 19941.245-for-1 share split
  5. 3 Jan 19941.03-for-1 share split
  6. 4 Jan 19931.04-for-1 share split

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.